Login

Register

  • Dates

  • Topics

  • Formats

  • Organiser

Organiser: GlobalBSG

The stringent regulations on safety monitoring increased the safety in data collection, analysis and regulatory surveillance. Adding to this the rising demand for drugs, the amplified need for novel therapeutics development via extensive clinical trials and the world population growth made drug manufacturers to start to pay more attention to Pharmacovigilance as public anxiety about safety increases.

Furthermore, the growth of exponential rare and chronic disease contributed to an increased need for drug development, therefore this led the industry to have a bigger focus on drug safety.

Register Now
Available Dates

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?

Logout
Close